The real-time PCR analysis of EGFR and KRAS mutations conducted in the present study, led to identification of EGFR c.2582T>A (L861Q) and KRAS c.35G>T (G12V), detected in 1,000–5,000 and 100–1,000 tumor cells, respectively. The gene discussed is EGFR; the disease is neoplasm.